Three LXR-targeted genes (CYP7A1, PLTP, and TTPA) were selected for further evaluation in liver tissue. Samples included 10 post-mortem confirmed eNAD-affected horses (n=9 classified as severe eNAD/EDM and n=1 classified as moderate eNAD; age range 1–2 years; median 1 year; n=3 females, n=7 males) and 9 unaffected horses (age range 0.5–13 years; median 2 years; n=6 females, n=3 males) (Table A.1). Age was not significantly different between groups (Mann-Whitney test; P=0.18). The 5 eNAD-affected and 5 unaffected horses used for RNA-seq of the spinal cord in this study were included in these samples. Primers for the genes of interest and 2 previously validated reference genes (ACTB, HPRT1) (6) were designed as described above (Table A.3). Reverse transcription, quantitative PCR reactions and data analyses were performed as described above.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.